Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review


  • Axel Brandes, Odense University Hospital, University of Southern Denmark
  • ,
  • Harry J G M Crijns, Maastricht University Medical Center
  • ,
  • Michiel Rienstra, University of Groningen
  • ,
  • Paulus Kirchhof, University of Birmingham
  • ,
  • Erik L Grove
  • Kenneth Bruun Pedersen, Odense University Hospital
  • ,
  • Isabelle C Van Gelder, Odense University Hospital, University of Southern Denmark, University of Groningen

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

Original languageEnglish
Pages (from-to)1149-1161
Number of pages13
Publication statusPublished - Aug 2020

See relations at Aarhus University Citationformats

ID: 185692401